Interview with Renate Shashoua, board member of Alpha1 Switzerland

By Editorial team Alpha1 Germany eV.February 1, 2019#!31Mon, 09 Mar 2020 17:31:59 +0100+01:005931#31Mon, 09 Mar 2020 17:31:59 +0100+01:00-5Europe/Berlin3131Europe/Berlin202031 09pm31pm-31Mon, 09 Mar 2020 17:31:59 +0100+01:005Europe/Berlin3131Europe/Berlin2020312020Mon, 09 Mar 2020 17:31:59 +0100315313pmMonday=2512#!31Mon, 09 Mar 2020 17:31:59 +0100+01:00Europe/Berlin3#March 9th, 2020#!31Mon, 09 Mar 2020 17:31:59 +0100+01:005931#/31Mon, 09 Mar 2020 17:31:59 +0100+01:00-5Europe/Berlin3131Europe/Berlin202031#!31Mon, 09 Mar 2020 17:31:59 +0100+01:00Europe/Berlin3#No Comments1 min read

Interview with Renate Shashoua, board member of Alpha1 Switzerland

santemedia.ch interviewed Renate Shashoua, board member of the Alpha-1 Switzerland association, about Alpha-1 antitrypsin deficiency.

Click here for the interview.

Would you like to learn more about the work of the Alpha-1 Association in Switzerland?

Click here to go to the website of the association in Switzerland.

Interview with Renate Shashoua, board member of Alpha1 Switzerland

Interview with Renate Shashoua, board member of Alpha1 Switzerland

Previous PostAlpha-1 antitrypsin deficiency: Rare mutations

Next PostThe ELF (European Lung Foundation) presents numerous topics related to the lungs in many languages.

Alpha1 Germany eV.